Mitochondria and the Link Between Neuroinflammation and Neurodegeneration

Abstract

Abstract. The innate immune response is thought to exert a dichotomous role in the brain. Indeed, although molecules of the innate immune response can promote repair mechanisms, during neuroinflammatory processes many harmful mediators are also released. Signs of neuroinflammation and neurodegeneration represent a ubiquitous pathological finding during the course of several different neurological diseases. Interestingly, it has been proposed that mitochondria may exert a crucial role in the pathogenesis of both inflammatory and neurodegenerative central nervous system disorders. In this review, we describe the mechanisms by which neuroinflammation and mitochondrial impairment may synergistically trigger a vicious cycle ultimately leading to neuronal death. In particular, we describe the close relationship existing among neuroinflammation, neurodegeneration, and mitochondrial impairment in three different widely-diffused neurological diseases in which these pathogenetic events coexist, namely multiple sclerosis, Parkinson's disease, and Alzheimer's disease.

Metformin Improves Neurologic Outcome Via AMP‐Activated Protein Kinase–Mediated Autophagy Activation in a Rat Model of Cardiac Arrest and Resuscitation

“…Consistent with previous studies, herein, our data demonstrate that long‐term metformin pretreatment affords strong neuroprotection and can be lifesaving under the conditions of CA/CPR. Moreover, our data show that metformin pretreatment suppresses the activation of microglia and astrocytes, which may represent part of the mechanism accounting for metformin‐mediated neuroprotection in CA/CPR because microgliosis and astrocytosis are well known to contribute to delayed neuronal loss and mitochondria dysfunction in ischemic brain injuries 41, 42, 43…”

Protective Effect of Lupeol Against Lipopolysaccharide-Induced Neuroinflammation via the p38/c-Jun N-Terminal Kinase Pathway in the Adult Mouse Brain

“…The neuroinflammatory process begins with the activation of glial cells, which generates a number of neurotoxic elements that include reactive oxygen species (ROS), nitric oxide species (NOS), cytokines, and other inflammatory mediators, all of which contribute to neurodegeneration (Skaper 2007; Di Haroon Badshah and Tahir Ali contributed equally to this work. Filippo et al 2010). Accordingly, Tansey et al stated that the production of these inflammatory cytokines and chemokines leads to the induction of apoptosis in various subsets of brain cells, including oligodendrocytes and astrocytes (Tansey et al 2009).…”

Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies

“…Meanwhile, high expression levels of both A2a and A2b receptors in the tumor microenvironment have sparked the interest of oncologists and medicinal chemists alike (Figure 16). 54 Although caffeine ( 25 ) is a weak and unspecific antagonist of all adenosine receptor subtypes, modern agents have significantly different structures and specificities to caffeine 55. Some companies decided to in‐license A2a receptor antagonists such as vipadenant ( 27 , Juno/Vernalis) and repurpose them for immuno‐oncology 56.…”